AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Brenner, T Arnon, R Sela, M Abramsky, O Meiner, Z Riven-Kreitman, R Tarcik, N Teitelbaum, D
Citation: T. Brenner et al., Humoral and cellular immune responses to Copolymer 1 in multiple sclerosispatients treated with Copaxone (R), J NEUROIMM, 115(1-2), 2001, pp. 152-160

Authors: Aharoni, R Teitelbaum, D Arnon, R Sela, M
Citation: R. Aharoni et al., Copolymer 1 inhibits manifestations of graft rejection, TRANSPLANT, 72(4), 2001, pp. 598-605

Authors: Aharoni, R Teitelbaum, D Leitner, O Meshorer, A Sela, M Arnon, R
Citation: R. Aharoni et al., Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1, P NAS US, 97(21), 2000, pp. 11472-11477

Authors: Fridkis-Hareli, M Aharoni, R Teitelbaum, D Arnon, R Sela, M Strominger, JL
Citation: M. Fridkis-hareli et al., Binding of random copolymers of three amino acids to class II MHC molecules, INT IMMUNOL, 11(5), 1999, pp. 635-641

Authors: Teitelbaum, D Arnon, R Sela, M
Citation: D. Teitelbaum et al., Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1, P NAS US, 96(7), 1999, pp. 3842-3847

Authors: Aharoni, R Teitelbaum, D Arnon, R Sela, M
Citation: R. Aharoni et al., Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basicprotein by T cell receptor antagonism in addition to major histocompatibility complex blocking, P NAS US, 96(2), 1999, pp. 634-639

Authors: Teitelbaum, D Aharoni, R Fridkis-Hareli, M Arnon, R Sela, M
Citation: D. Teitelbaum et al., Development of copolymer 1 (Copaxone (R)) as a specific drug against multiple sclerosis, DECADE OF AUTOIMMUNITY, 1999, pp. 191-196

Authors: Aharoni, R Teitelbaum, D Sela, M Arnon, R
Citation: R. Aharoni et al., Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1, J NEUROIMM, 91(1-2), 1998, pp. 135-146
Risultati: 1-8 |